BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 29952252)

  • 1. Stent fractures after common femoral artery bail-out stenting due to suture device failure in TAVR.
    Veulemans V; Afzal S; Ledwig P; Heiss C; Busch L; Sansone R; Soetemann DB; Maier O; Kleinebrecht L; Kelm M; Zeus T; Hellhammer K
    Vasa; 2018 Aug; 47(5):393-401. PubMed ID: 29952252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short and long-term results after endovascular management of vascular complications during transfemoral aortic valve implantation.
    Heger T; Strauß S; Blessing E; Andrassy M; Erbel C; Müller OJ; Chorianopoulos E; Pleger S; Leuschner F; Korosoglou G; Bekeredjian R; Katus HA; Vogel B
    Acta Cardiol; 2017 Aug; 72(4):474-482. PubMed ID: 28705072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of Stent Graft Implantation for Treatment of Access Site Bleeding After Transfemoral Transcatheter Aortic Valve Replacement.
    Segal A; Flugelman MY; Khader N; Rubinshtein R; Lavi I; Karmeli R; Jubran A; Shiran A; Jaffe R
    Am J Cardiol; 2017 Aug; 120(3):456-460. PubMed ID: 28583682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcomes of Iliofemoral Artery Stents after Transfemoral Aortic Valve Replacement.
    Grossman Y; Silverberg D; Berkovitch A; Chernomordik F; Younis A; Asher E; Barbash I; Halak M; Guetta V; Segev A; Fefer P
    J Vasc Interv Radiol; 2018 Dec; 29(12):1733-1740. PubMed ID: 30297312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of an ePTFE-covered nitinol self-expanding stent graft for the treatment off pre-closure device failure during transcatheter aortic valve replacement.
    Steinvil A; Bernardo N; Rogers T; Koifman E; Buchanan K; Alraies MC; Shults C; Torguson R; Okubagzi PG; Pichard AD; Satler LF; Ben-Dor I; Waksman R
    Cardiovasc Revasc Med; 2017 Mar; 18(2):128-132. PubMed ID: 27865711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
    Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
    J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, randomized, controlled trial of totally percutaneous access versus open femoral exposure for endovascular aortic aneurysm repair (the PEVAR trial).
    Nelson PR; Kracjer Z; Kansal N; Rao V; Bianchi C; Hashemi H; Jones P; Bacharach JM
    J Vasc Surg; 2014 May; 59(5):1181-93. PubMed ID: 24440678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
    Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM;
    J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic Retrograde Distal Common Femoral Access as a Bail-out Strategy in Patients with Increased Risk for Femoral Access Complication During Transfemoral Aortic Valve Replacement.
    Sanghvi K; Swarup S; Burns P; Kovach R; Ross R; Soussa T
    Cardiovasc Revasc Med; 2020 Apr; 21(4):481-485. PubMed ID: 31375463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral stent patency in fenestrated stent grafting for abdominal aortic aneurysm repair.
    Grimme FA; Zeebregts CJ; Verhoeven EL; Bekkema F; Reijnen MM; Tielliu IF
    J Vasc Surg; 2014 Feb; 59(2):298-306. PubMed ID: 24080136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iliofemoral endarterectomy associated with systematic iliac stent grafting for the treatment of severe iliofemoral occlusive disease.
    Maitrias P; Deltombe G; Molin V; Reix T
    J Vasc Surg; 2017 Feb; 65(2):406-413. PubMed ID: 27693029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Common femoral artery bailout stenting with covered stent graft due to TAVR vascular complication: Clinical long term follow-up].
    Drouelle E; De Poli F; Couppie P; Uhry S; Heyer H; Morel O; Ohlmann P; Hess S; Kibler M; Leddet P
    Ann Cardiol Angeiol (Paris); 2019 Nov; 68(5):316-324. PubMed ID: 31570157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iliac Artery Stenting Combined with Ipsilateral Open Femoro-Popliteal Revascularization and Its Effect on Bypass Patency.
    Piazza M; Squizzato F; Lepidi S; Menegolo M; Grego F; Antonello M
    Ann Vasc Surg; 2017 Oct; 44():282-288. PubMed ID: 28479462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
    Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
    J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrograde Femoral Artery Stent-Graft Implantation for Treatment of Access-site Bleeding Following Transcatheter Aortic Valve Implantation.
    Sliman H; Shiran A; Mannheim D; Avraham E; Karmeli R; Khader N; Zafrir B; Rubinshtein R; Jaffe R
    Isr Med Assoc J; 2019 May; 21(5):322-325. PubMed ID: 31140223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endovascular aortic aneurysm repair in patients with narrow aortas using bifurcated stent grafts is safe and effective.
    Strajina V; Oderich GS; Fatima J; Gloviczki P; Duncan AA; Kalra M; Fleming M; Macedo TA
    J Vasc Surg; 2015 Nov; 62(5):1140-7.e1. PubMed ID: 26372194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine Endovascular Treatment With a Stent Graft for Access-Site and Access-Related Vascular Injury in Transfemoral Transcatheter Aortic Valve Implantation.
    Sedaghat A; Neumann N; Schahab N; Sinning JM; Hammerstingl C; Pingel S; Schaefer C; Mellert F; Schiller W; Welz A; Grube E; Nickenig G; Werner N
    Circ Cardiovasc Interv; 2016 Aug; 9(8):. PubMed ID: 27512089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of routine crossover balloon occlusion technique on access-related vascular complications following transfemoral transcatheter aortic valve replacement.
    Zaman S; Gooley R; Cheng V; McCormick L; Meredith IT
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):276-84. PubMed ID: 27107395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of covered stent placement for central venous occlusive disease in hemodialysis patients.
    Anaya-Ayala JE; Smolock CJ; Colvard BD; Naoum JJ; Bismuth J; Lumsden AB; Davies MG; Peden EK
    J Vasc Surg; 2011 Sep; 54(3):754-9. PubMed ID: 21664095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stent fractures after superficial femoral artery stenting: risk factors and impact on patency.
    Lin Y; Tang X; Fu W; Kovach R; George JC; Guo D
    J Endovasc Ther; 2015 Jun; 22(3):319-26. PubMed ID: 25862365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.